|
|
| Friday June 4, 2004 |
| Infertility
|
| 08:15 - 09:45
|
Opening Plenary Session |
|
Chairperson:
|
Z. Ben-Rafael, Israel
R. Lobo, USA
|
| |
Opening remarks
R. Lobo, USA |
| 1. |
The ethics of
Caesarian section on demand
F. Chervenak, USA
|
| 2. |
"Snakes, bugs
and us" (Spouses are invited)
S. Granai, USA
|
| |
|
| 09:45 - 10:15
|
Break |
| |
|
| 10:15 - 11:45 |
PCOS |
|
Chairperson:
|
A. DeCherney, USA
M. Yemini, USA
|
|
Capsule: The most common endocrinopathy
remains an enigma in many aspects |
| 1.
|
Should
metformin be used routinely for all women with PCOS?
R. Lobo, USA |
| 2. |
What is
the best regimen for clomiphene failures?
R. F. Casper, Canada
|
| 3. |
Ovarian hyperstimulation syndrome in ART, is it a real problem?
Z. Ben Rafael, Israel |
| 4. |
Laparoscopic
ovarian cautery - correlation of number of puncture and clinical outcome
O. Shawki, Egypt
|
| |
|
| 11:45 - 13:45
|
The Patient Journey: Issues of Infertility, Conception,
Multiple Gestation and Prematurity? Supported through an unrestricted
educational grant from Serono (Lunch Session) |
| |
|
| 14:00 - 15:30
|
Minimal Workup Before Infertility Treatment
- Endorsed by the Tarnesby Chair of Fertility Regulation
|
|
Chairperson:
|
S. Corson, USA
N. Gleicher, USA
|
| |
Capsule: Can we do without some of
the tests?
|
| 1.
|
Diagnostic Laparoscopy ever indicated?
V. Gomel, USA |
| 2. |
Sophisticated sperm
analysis ever required?
D. Evenson, USA
|
| 3. |
Why so much mis-diagnosis with Hysterosalpingography?
A. DeCherney, USA |
| 4. |
Clinical Applications of Transvaginal Hydrolaparoscopy
M. Surrey, USA
|
| |
|
| 15:30 - 16:00 |
Coffee Break |
| |
|
| 16:00 - 17:30 |
Conservative Treatment of Fibroids
|
|
Chairpersons:
|
V. Gomel, USA
T. Falcone, USA
|
| |
Capsule: Delaying childbearing increases
the need for conservative treatment of fibroids |
| 1. |
Management
of intramural fibroids in infertility
A. DeCherney, USA |
| 2. |
Is there a
place for GnRH agonists before myomectomy?
S. Corson, USA |
| 3. |
Laparoscopic Myomectomy - should it be done in all cases?
A. Ternamian, Canada
|
| |
|
| 17:30 - 18:15
|
Controversies in Reproductive Medicine
|
|
Chairperson:
|
M. Alper, USA
|
|
1.
|
Preimplantation
genetic diagnosis
L. Werlin, USA |
|
2.
|
Preconception
Sex Selection: Current MicroSort® Clinical Trial Results
D.S. Karabinus, USA
|
| 3. |
The
role of tubal surgery in the era of ART
S. El Sahwi, Egypt |
| |
| Friday, June 4, 2004 |
| Perinatology |
| 10:15 - 11:45 |
Prenatal Screening and Diagnosis
|
|
Chairpersons:
|
L. Platt, USA
D. Nyberg, USA |
|
|
Capsule: There is still no agreed policy
on how best to screen for fetal anomalies
|
| 1. |
First
trimester screening - the BUN experience
R. Wapner, USA |
| 2. |
First trimester screening - the faster experience
M. D'Alton, USA |
| 3. |
Prenatal
screening and diagnosis
M. J. Sinosich, Australia |
| |
|
| 11:45 - 14:00
|
Lunch Session
|
| |
|
| 14:00 - 15:30
|
Prenatal Screening and Analysis
|
|
Chairperson:
|
M. D'alton, USA
E. Norwitz, USA
|
| |
Capsule: There is still
no agreed policy on how best to screen for fetal anomalies |
| 1. |
Second Trimester
Genetic Sonogram- How does it fit in?
D. Nyberg, USA
|
| 2. |
The role of 3D in screening for malformations
L. Platt, USA |
| 3. |
Methods
to Increase the Percentage of Free Fetal DNA Recovered from Maternal Blood
Samples and the Implications for a Non-Invasive Prenatal Test
R. Dhallan, USA
|
|
| |
|
| 15:30 - 16:00
|
Coffee Break
|
| |
|
| 16:00 - 17:30 |
Prematurity
|
|
Chairpersons:
|
S. Gaddipati, USA
R. Berkowitz, USA |
| |
Capsule: The debate continues.
Can we decrease mortality and morbidity? |
| 1. |
Severe
pre-eclampsia at the limit of viability - Is there a role for expectant
management?
E. Norwitz, USA
|
| 2. |
Spontaneous preterm labour: a fetomaternal adaptive response
J. Gardosi, UK
|
| 3. |
Preterm
labor, infection and cerebral palsy
E. Norwitz, USA
|
| |
|
| 17:30 - 18:45
|
Controversies in Perinatology |
|
Chairpersons:
|
E. Norwitz, USA
J. Gardosi, UK
|
| 1. |
Recombinant
factor VIIa use to overcome massive fatal postpartum hemorrhage
S. Segal, Israel
|
| 2. |
Acupuncture
as a technique for inducing uterine contractions in term pregnant patients: a
preliminary study
A. Martinez, The Philippines |
| 3. |
Epidural
analgesia in a low-dose oxytocin setting increases the risk of caesarian
section: a critical look at the external validity of randomized trials
A. Kotaska, Canada
|
|
|
| Friday, June 4, 2004 |
| Gynecology |
| 10:15 - 11:45 |
Laparoscopy
|
|
|
|
Chairpersons:
|
V. Gomel, USA
R. Zurawin, USA
|
| |
Capsule: Laparoscopy is a potent operative
tool, but the debate over safety and indications still go on |
| 1. |
Laparoscopic hysterectomy, why is it not more popular?
T. Falcone, USA |
| 2. |
Laparoscopic
access safety
A. Ternamian, Canada
|
| 3. |
Laparoscopic burch - fancy operation or real need?
T. Falcone, USA |
| |
|
| 11:45 - 14:00
|
Lunch Break
|
| |
|
| 14:00 - 15:30
|
Sexual Dysfunction
|
|
Chairperson:
|
G. Bachmann, USA
|
| |
Capsule: Should we use agents intended to treat male
erectile dysfunction in women?
|
| 1. |
The use of Sildenafil in women
|
| 2. |
How do we define sexual desire / arousal problems in women?
G. Bachmann, USA
|
| 3. |
Androgen
treatment for hypoactive sexual desire?
G. Kovalevsky, USA
|
| 4. |
The
scientific rationale for androgen therapy in post-menopausal women
M. Notelovitz, USA
|
| |
|
| 15:30 - 16:00 |
Coffee Break |
| |
|
| 16:00 - 17:30
|
Oncology Session
|
|
Chairpersons:
|
P.E. Schwartz, USA
K. Narayan, Australia
|
|
|
Capsule: Preservation of fertility
is a goal in young women |
| 1. |
Preservation
of fertility in women with Stage IB1 cervical cancer
M. Roy, Canada
|
| 2. |
Neoadjuvant
chemotherapy for advanced ovarian cancer
P.E. Schwartz, USA |
| 3. |
Laparoscopic
approach to pelvic masses
M. Roy, Canada
|
| 4. |
Relevance of
current FIGO staging for cervical cancer
K. Narayan, Australia
|
| |
|
| 17:30 - 18:45 |
Controversies in Gynecology |
|
Chairperson:
|
M. Roy, Canada
|
| 1. |
Chronic pelvic pain: exploring bladder etiologies
B. Kahn,
USA
|
| 2. |
Ovarian tumor
suspected during first trimester pregnancy
C-N. Fang, Taiwan
|
| 3. |
Prevention and early detection of reproductive cancers
V. Manvelyan, Armenia
|
| 4. |
Efficacy of hyaluronate / carboxymethylcelluloe membrane for reducing of
postoperative adhesion formation in uterine horn model in rats
S. Kelekci, Turkey
|
| |
|
| Saturday, June 5, 2004 |
| Infertility
|
| 08:00 - 10:00 |
New Technologies in IVF
|
|
Chairperson:
|
R. Casper, USA
|
| |
Capsule: With all the technological
improvements the question remains, are we progressing? |
| 1. |
Does ART increase
imprinting disorders?
J. Cohen, USA
|
| 2. |
Human
reproduction and the biological basis of developmental plasticity
G. Schatten, USA |
| 3. |
Should
we stop ovarian crypreservation?
J. Schenker, Israel |
| 4. |
Ovarian banking - Skepticism or enthusiasm?
S. Kim, USA |
| |
|
| 10:30 - 12:30 |
Industry Sponsored Symposium supported by an unrestricted educational grant by
Ferring Pharmaceuticals |
| |
Clinical Reality: Facts to consider when choosing your Gonadotropin
|
| 1. |
Recombinant and Urinary Gonadotropins: Comparison of Efficacy,
Safety and Consistency
S. Chappel, USA
|
| 2. |
A Markov Model of the Cost Effectiveness of Human-Derived FSH versus
Recombinant FSH Using Comparative Clinical Trial Data
H. Hatoum, USA
|
| 3. |
Improving the efficacy, safety, cost-effectiveness and acceptability of
gonadotropin administration prior to in vitro fertilization
W. Keye, USA
|
| |
|
12:30 - 14:30
|
Osteoporosis Prevention in The Postmenopausal Woman - A New - Old dilemma?
Funded by an Unrestricted Educational Grant from Schering AG, Germany and Berlex
Inc., the US affiliate of Schering AG, Germany
|
| |
|
| 14:30 - 16:00
|
New Technologies in IVF II
|
|
Chairperson:
|
J. Cohen, USA |
| |
Capsule: Stem-cells - why we need them
and where do we get them from |
| 1. |
Assisted regenerative technologies: ART's future for deriving immune-matched
stem cells
G. Schatten, USA |
| 2. |
Human
umbilical cord blood stem cells: can they replace embryonic stem cells?
R.F. Casper, Canada
|
| 3. |
Is
preconception gender selection ethical?
C. Lockwood, USA
|
| |
|
| 16:00 - 16:30
|
Coffee Break |
| |
|
| 4. |
Avoidance of OHSS -
step up, step down or other
S. Daya, Canada
|
| |
| Saturday, June 5, 2004 |
| Perinatology
|
| 08:00 - 10:00 |
Coping With Infection in Obstetrics
|
|
Chairperson:
|
A.A. Fanaroff, USA |
| |
Capsule: Controversies exist regarding
aspects of screening and management of infectious disease during pregnancy |
| 1. |
Prevention of perinatal infection - GBS and other
A.A. Fanaroff, USA |
| 2. |
GBS: Who,
when and which screening approach should be used for GBS screening and
intra-partum therapy?
S. Gaddipati , USA |
| 3. |
CMV - time for
screening?
Z. Hagay, Israel |
| 4. |
HIV in
pregnancy - what's next?
S. Gaddipati , USA |
| |
|
| 10:30 - 12:30 |
Complications of Pregnancies
|
|
Chairpersons:
|
R. Berkowitz, USA
J. Gardosi, UK
|
| |
Capsule: Despite many years of experience
and debate, basic questions in obstetrics remain unanswered |
| 1. |
How do iatrogenic multiple pregnancies complicate perinatal care?
M. D'Alton, USA |
| 2. |
Who is
afraid of triplets? Reconsidering multifetal pregnancy reduction
I. Blickstein, Israel |
| 3. |
Hypoxic
ischemic encephalopathy - the ACOG criteria
R. Bukowski, USA |
| 4. |
The brain damaged baby and the obstetrician
R. Berkowitz, USA |
| |
|
| 12:30 - 14:30
|
Lunch Sponsored Session
|
| |
|
| 14:30 - 16:00
|
Thrombophilia in Obstetrics and Gynecology
|
|
Chairperson:
|
R. Bukowski, USA
M. D'Alton, USA |
|
|
Capsule: Can screening and treatment
of thrombophilia prevent complications?
|
| 1.
|
What
is the evidence for the relation of thrombophilia to adverse pregnancy outcome?
C. Lockwood, USA
|
| 2. |
The value of
LMWH treatment in Ob/Gyn?
D. Blickstein, Israel
|
| 3.
|
Prevention
of venous thromboembolism in gynecologic surgery
D. Clarke Pearson, USA
|
| 4. |
Thrombophilia assessment: what should guidelines look like?
D. Blickstein, Israel
|
| |
|
| 16:00 - 16:30
|
Coffee Break |
| |
|
| 16:30 - 18:30
|
Intrauterine Growth Restriction
|
|
Chairpersons:
|
J. Gardosi, UK
R. Bukowski, USA |
| |
Capsule: What are the most appropriate
strategies for preventing complications due to growth problems?
|
| 1.
|
Epidemiology and perinatal sequelae
J. Gardosi, UK
|
| 2. |
Fetal
growth potential
R. Bukowski, USA |
| 3. |
Fetal growth in twins
S. M. Kady, UK
|
| 4. |
Clinical assessment, ultrasound and doppler
J. Gardosi, UK
|
|
|
| Saturday, June 5, 2004 |
| Gynecology
|
| |
Hysteroscopy
|
|
Chairpersons:
|
S. Corson, USA
M. Glasser, USA |
| 1. |
Postmenopausal
hysteroscopy as a screening test for all women
S. Bettocchi, Italy
|
| 2. |
Minihysteroscopy
vs. standard technique for diagnosis
E. Cicinelli, Italy
|
| 3. |
The
HTA treatment of menorrhagia in women with abnormal uterine cavities
M. Glasser, USA |
| 4. |
Fluid management of hysteroscopy
S. Corson, USA |
| 5. |
TBA
P.Brooks, USA |
| |
|
| 10:00 - 10:30 |
Coffee Break |
| |
|
| 10:30 - 12:30 |
Transdermal Hormone Delivery
|
|
Chairperson:
|
R. Lobo, USA
M. Notelovitz, USA |
| |
Capsule: Should transdermal
route be preferred over the oral administration? |
| 1. |
Advantages of transdermal system over oral therapy
S. Corson, USA |
| 2. |
Efficacy of transdermal systems for symptomatic women
G. Kovalevsky, USA |
| 3. |
Metabolic changes and osteoporosis prevention with oral vs. non-oral estrogens
G. Bachmann, USA
|
| |
|
| 12:30 - 14:30
|
Lunch Sponsored Session
|
| |
|
| 14:30 - 16:00
|
The Evolution and Revolution in Contraception |
|
Chairperson:
|
R. Adatto, Israel
R. Zurawin, USA
|
| |
Capsule: Will the innovative methods of
family planning replace the Pill? |
| 1. |
The levonorgestrel IUS - just a contraceptive?
R. Arias, USA
|
| 2. |
Will the
patch replace the Pill?
G. Kovalevsky, USA
|
| 3. |
The case for extended dose oral contraception
|
| 4. |
Hysteroscopic
sterilization - why use anything else?
R. Zurawin, USA |
| |
|
| 16:00 - 16:30
|
Coffee Break
|
| |
|
| |
|
| Sunday, June 6, 2004 |
| Infertility
|
| 06:30 - 08:00
|
Practical IVF
|
|
Chairperson:
|
N. Gleicher, USA
H. Sallam, Egypt
|
| |
Capsule: Many practical
issues are unsettled |
| |
Should we limit
the number of embryo transferred: the review
N. Gleicher, USA
|
| |
Does ET
technique matter?
H. Salam, Egypt
|
| |
Minimal monitoring
of ovarian stimulation – is it safe?
Z. Shoham, Israel
|
| |
Avoidance of OHSS -
step up, step down or other
S. Daya, Canada
|
| |
|
| 08:00 - 10:00 |
PGD |
| Chairperson: |
J. Cohen, USA
L. Gianaroli, Italy
|
| |
Capsule: What can be gained, what are
the pitfalls? |
| 1.
|
Does PGD affect
IVF pregnancy rates?
L. Gianarolli, Italy
|
| 2. |
PGD - polar body or blastomere - what to prefer?
Y. Verlinsky, USA |
| 3. |
Does nuclear transfer have a place?
J. Cohen, USA |
| 4. |
Should PGD laboratories be regulated?
Y. Verlinsky, USA |
| |
|
| 10:00 - 10:30 |
Coffee Break
|
| |
|
| 10:30 - 12:30 |
Endometriosis
|
|
Chairperson:
|
D. Redwine, USA
L. Hummelshoj, UK
|
| |
Capsule: Can we choose between the
many options of therapy of this poorly understood condition?
|
| 1. |
The relationship of endometriosis and chronic pain: cause or
association
C. Miller, USA
|
| 2. |
Meeting
expectations in the chronically ill patient by extending the therapeutic
network
L. Hummelshoj , UK |
| 3.
|
Should
laser vaporisation and electrocoagulation of endometriosis be banned?
D.B. Redwine, USA
|
| 4.
|
Treatment of endometriosis in the adolescent
C. Miller, USA
|
| |
|
| Sunday, June 6, 2004 |
| Perinatology
|
| 08:00 - 10:00 |
Complications of Pregnancy and Postnatal Care
|
|
Chairperson:
|
A. Fanaroff, USA
E. Shinwell, Israel
|
| |
Capsule: State of the art: Care for
the fetus and newborn in 2004 |
| 1. |
Perinatal and neonatal dilemmas at the limits of viability
A. A. Fanaroff, USA |
| 2. |
Postnatal
steroid therapy and other adverse influences on the neonatal brain
E. Shinwell, Israel
|
| 3. |
NST ad BPP in the management of the IUGR fetus: are we delivering
too late?
|
| 4. |
Surfactant
and other respiratory therapy - is there any hard evidence?
E. Shinwell, Israel
|
| |
|
| 10:00 - 10:30
|
Coffee Break
|
| |
|
| 10:30 - 12:30 |
Hot Controversies Regarding Delivery
|
|
Chairperson:
|
Z. Hagay, Israel
L. Keith, USA
|
|
|
Capsule: Many questions over the risks
of delivery remain unanswered
|
| 1. |
Is there any
controversy over breech deliveries?
R. Artal, USA |
| 2. |
Do parturients over
40 represent a new obstetric entity?
L. G. Keith, USA |
| 3. |
Can shoulder dystocia be prevented? What is the price?
I. Blickstein, Israel
|
| 4. |
The Incompetent Cervix - The Perennial Controversy
R. Artal, USA |
| |
|
| Sunday, June 6, 2004 |
| Gynecology
|
| 06:30 - 08:00 |
Cervical Cancer and HPV
|
|
Chairpersons:
|
D. A. Fishman, USA
R. Moore, USA
|
| |
Capsule: Should we screen for this
risk factor? Can we prevent it? |
| 1. |
HPV DNA
typing has no role in the routine evaluation of the abnormal Pap smear
P.E. Schwartz, USA |
| 2. |
HPV vaccines why
aren't they the answer yet
R. Moore, USA
|
| 3. |
Cervical pre-malignant changes do not begin until CIN II
M. Yu, USA |
| |
|
| 08:00 - 10:00 |
Treating Menopausal Women Under the WHI Shadow
|
| |
Capsule: Do we have to
change our prescribing habits? |
|
Chairperson:
|
G. Bachmann, USA
G. Kovalevsky, USA
|
| 1. |
Increased
risk of breast cancer precludes the use of hormones
M. Notelowitz |
| 2. |
Hormonal
therapy increases not decreases cardiovascular risks
R. Lobo, USA |
| 3. |
The use of progestogens magnifies the risks observed in WHI
TBA
|
| 4. |
Estrogen and
progestogen therapy - should it be used for primary prevention of osteoporosis
H. Schneider, Germany
|
| |
|
| 10:00 - 10:30 |
Coffee Break
|
| |
|
| 10:30 - 12:30 |
Early Detection of Breast and Gynecologic Malignancies
|
|
Chairpersons:
|
D.A. Fishman, USA
P.E. Schwartz, USA
|
| |
Capsule: Delayed diagnosis is the major
problem affecting prognosis - Can we diagnose it earlier? |
| 1. |
Early detection of breast cancer. How feasible it is?
E. Petricoin, USA |
| 2. |
Proteomics for early detection of ovarian cancer; is this the
answer?
E. Petricoin, USA
|
| 3. |
Clinical
application of newer methods- the National Ovarian Cancer Early Detection
Program
D.A. Fishman, USA
|
| 4. |
Prophylactic
Oophorectomy in BRCA carriers with or W/O hysterectomy
P.E. Schwartz, USA |
